Paper9747872
Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP.
Suzuki A and 4 others. Oncogene, 1998. Cited by 320 papers, by iCite.
Cite this record
ConductScience Library. Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP. Papers, record 9747872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9747872
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Resistance to Fas-mediated apoptosis: activation of caspase 3 is regulated by cell cycle regulator p21WAF1 and IAP gene family ILP.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Apoptosis | Major topic |
| Caspases | Major topic |
| Cyclins | Major topic |
| Cysteine Endopeptidases | Major topic |
| Proteins | Major topic |
| fas Receptor | Major topic |
| Antibodies, Monoclonal | |
| Carcinoma, Hepatocellular | |
| Caspase 3 | |
| Cyclin-Dependent Kinase Inhibitor p21 | |
| Cysteine Proteinase Inhibitors | |
| Enzyme Activation | |
| Enzyme Precursors | |
| Humans | |
| Inhibitor of Apoptosis Proteins | |
| Multigene Family | |
| Precipitin Tests | |
| Tumor Cells, Cultured | |
| X-Linked Inhibitor of Apoptosis Protein |
Source PubMed
Cited by123
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 320 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39819515 | Transcriptomic landscape of Hras12V oncogene-induced hepatocarcinogenesis with gender disparity. | BMC Cancer | 2025 | https://conductscience.org/library/papers/39819515 | PubMed |
| 39684919 | The Emerging Role of p21 in Diabetes and Related Metabolic Disorders. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39684919 | PubMed |
| 36714540 | Combined treatments with AZD5363, AZD8542, curcumin or resveratrol induce death of human glioblastoma cells by suppressing the PI3K/AKT and SHH signaling pathways. | Biochem Biophys Rep | 2023 | https://conductscience.org/library/papers/36714540 | PubMed |
| 36510032 | Formal verification confirms the role of p53 protein in cell fate decision mechanism. | Theory Biosci | 2023 | https://conductscience.org/library/papers/36510032 | PubMed |
| 36158087 | PKC signal amplification suppresses non-small cell lung cancer growth by promoting p21 expression and phosphorylation. | Heliyon | 2022 | https://conductscience.org/library/papers/36158087 | PubMed |
| 35754740 | Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A. | iScience | 2022 | https://conductscience.org/library/papers/35754740 | PubMed |
| 35280788 | A Novel Copper(II) Indenoisoquinoline Complex Inhibits Topoisomerase I, Induces G2 Phase Arrest, and Autophagy in Three Adenocarcinomas. | Front Oncol | 2022 | https://conductscience.org/library/papers/35280788 | PubMed |
| 34878965 | p53-mediated G1 arrest requires the induction of both p21 and Killin in human colon cancer cells. | Cell Cycle | 2022 | https://conductscience.org/library/papers/34878965 | PubMed |
| 34698969 | KIF21A regulates breast cancer aggressiveness and is prognostic of patient survival and tumor recurrence. | Breast Cancer Res Treat | 2022 | https://conductscience.org/library/papers/34698969 | PubMed |
| 34359573 | Anastasis: Return Journey from Cell Death. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359573 | PubMed |
| 34131243 | Susceptibility of cyclin-dependent kinase inhibitor 1-deficient mice to rheumatoid arthritis arising from interleukin-1β-induced inflammation. | Sci Rep | 2021 | https://conductscience.org/library/papers/34131243 | PubMed |
| 33567474 | The immunoregulatory role of p21 in the development of the temporomandibular joint-osteoarthritis. | Clin Exp Dent Res | 2021 | https://conductscience.org/library/papers/33567474 | PubMed |
| 33486250 | Curcumin suppresses cell growth and attenuates fluoride-mediated Caspase-3 activation in ameloblast-like LS8 cells. | Environ Pollut | 2021 | https://conductscience.org/library/papers/33486250 | PubMed |
| 33382987 | Spinal motor neuron loss occurs through a p53-and-p21-independent mechanism in the Smn2B/- mouse model of spinal muscular atrophy. | Exp Neurol | 2021 | https://conductscience.org/library/papers/33382987 | PubMed |
| 33304321 | CCN3 Signaling Is Differently Regulated in Placental Diseases Preeclampsia and Abnormally Invasive Placenta. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/33304321 | PubMed |
| 33147101 | Guanine nucleotide binding protein like-1 (GNL1) promotes cancer cell proliferation and survival through AKT/p21 CIP1 signaling cascade. | Mol Biol Cell | 2020 | https://conductscience.org/library/papers/33147101 | PubMed |
| 31852915 | Increased double strand breaks in diabetic β-cells with a p21 response that limits apoptosis. | Sci Rep | 2019 | https://conductscience.org/library/papers/31852915 | PubMed |
| 31217743 | Zoledronate induces cell cycle arrest and differentiation by upregulating p21 in mouse MC3T3-E1 preosteoblasts. | Int J Med Sci | 2019 | https://conductscience.org/library/papers/31217743 | PubMed |
| 31097688 | Thr55 phosphorylation of p21 by MPK38/MELK ameliorates defects in glucose, lipid, and energy metabolism in diet-induced obese mice. | Cell Death Dis | 2019 | https://conductscience.org/library/papers/31097688 | PubMed |
| 31083332 | MDM2-Mediated p21 Proteasomal Degradation Promotes Fluoride Toxicity in Ameloblasts. | Cells | 2019 | https://conductscience.org/library/papers/31083332 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALPI | 248 | PubTator's text mining | https://conductscience.org/library/genes/248 | NCBI Gene |
| CASP3 | 836 | PubTator's text mining | https://conductscience.org/library/genes/836 | NCBI Gene |
| CCNL2 | 81669 | PubTator's text mining | https://conductscience.org/library/genes/81669 | NCBI Gene |
| CDKN1A | 1026 | PubTator's text mining | https://conductscience.org/library/genes/1026 | NCBI Gene |
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
| H3P16 | 644914 | PubTator's text mining | https://conductscience.org/library/genes/644914 | NCBI Gene |
| XIAP | 331 | PubTator's text mining | https://conductscience.org/library/genes/331 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9747872
GET https://conductscience.org/api/papers/v1/9747872/cited_by?page=2